Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...

It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than standard plerixafor.

Although approximately 1 in 6 people worldwide are living with a significant disability, the narrative that those of us with disabilities deserve less continues to be perpetuated. Though frustrating, ...